Global consensus: Management of epithelioid hemangioendothelioma

Uncertainty of appropriate treatment and lack of guideline on management of the ultra-rare cancer disorder epithelioid hemangioendothelioma (EHE), has led to a global consensus meeting at ESMO 2020. In this MEDtalk, MD Silvia Stacchiotti presents the consensus achieved during that meeting including evidence-based best practices for the optimal approach to primary and metastatic EHE.